Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.

Ingram, N, Northwood, EL, Perry, SL et al. (7 more authors) (2013) Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations. Carcinogenesis, 34 (10). 2341 - 2349. ISSN 0143-3334

Abstract

Metadata

Authors/Creators:
  • Ingram, N
  • Northwood, EL
  • Perry, SL
  • Marston, G
  • Snowden, H
  • Taylor, JC
  • Scott, N
  • Bishop, DT
  • Coletta, PL
  • Hull, MA
Copyright, Publisher and Additional Information: (c) 2013, The Authors. This is an Open Access article distributed in accordance with the Creative Commons Attribution (CC BY 3.0) licence, which permits others to distribute, remix, adapt, build upon this work, and license their derivative works on different terms, provided the original work is properly cited.
Keywords: Aged; Animals; Case-Control Studies; Cell Transformation, Neoplastic; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Humans; Male; Mice; Mice, Knockout; Mice, Transgenic; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Interleukin-4, Type II; Risk Factors; Signal Transduction
Dates:
  • Published: October 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 Mar 2015 11:54
Last Modified: 03 Nov 2017 04:13
Published Version: http://dx.doi.org/10.1093/carcin/bgt222
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/carcin/bgt222

Share / Export

Statistics